Key Takeaways
- HHS is proposing to reorganize the FDA to remove unnecessary management layers and offices and streamline it into five shared services offices.
- However, the proposal was developed by someone who does not understand the agency and all of its responsibilities, former FDA official Janet Woodcock said.
- The varied products that the agency regulates demand highly specialized expertise, which would be lost under the proposal, former Principal Deputy Commissioner Joshua Sharfstein said.
A proposal for reorganizing the US Food and Drug Administration into five offices and consolidating all product review functions is “a mindless approach to centralization and standardization” and would not
The proposal for a reorganized FDA that is being circulated by the Trump administration “is a really, really bad idea,” says Janet Woodcock, former
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?